Shehnaaz Suliman
Director · 5 filings · Latest: Sep 22, 2026
10x Genomics, Inc.
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TXG | Shehnaaz Suliman | Director | Sep 22, 2026 | Sale | $81.19 | 5,723 | $464.7K | 23,792 | |
TXG | Shehnaaz Suliman | — | Sep 22, 2026 | Proposed Sale | $79.10 | 5,723 | $452.7K | — | |
TXG | Shehnaaz Suliman | Director | Aug 24, 2026 | Sale | $63.65 | 2,207 | $140.5K | 29,515 | |
TXG | Shehnaaz Suliman | — | Aug 24, 2026 | Proposed Sale | $65.12 | 2,207 | $143.7K | — | |
TXG | Shehnaaz Suliman | Director | Jun 16, 2026 | Sale | $32.63 | 5,723 | $186.8K | 31,722 | |
TXG | Shehnaaz Suliman | — | Jun 16, 2026 | Proposed Sale | $32.22 | 5,723 | $184.4K | — | |
RARE | Shehnaaz Suliman | Director | May 18, 2026 | Sale | $25.12 | 5,740 | $144.2K | 27,951 | |
RARE | SHEHNAAZ SULIMAN | — | May 18, 2026 | Proposed Sale | $25.12 | 5,740 | $144.2K | — |